[{"NetIncomeLoss_1_Q2_USD":-16274000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":9445000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5086000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":40151802.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":40247110.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_2_Q2_USD":-0.76,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q2_USD":-0.4,"CommitmentsAndContingencies_0_Q2_USD":null,"FinanceLeaseLiabilityPaymentsDueInRollingYearTwo_0_Q2_USD":288000.0,"InterestPaidNet_2_Q2_USD":3000.0,"IncomeTaxesPaid_2_Q2_USD":274000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-7000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":3000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-6000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-3000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":412277000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_0_Q2_USD":519000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":489000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4421243.0,"FinanceLeaseInterestExpense_2_Q2_USD":6000.0,"FinanceLeaseInterestExpense_1_Q2_USD":3000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":464000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":18000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":216000.0,"CommonStockSharesIssued_0_Q2_shares":40325270.0,"OperatingLeaseLiability_0_Q2_USD":2058000.0,"Assets_0_Q2_USD":421289000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":2291000.0,"FinanceLeaseLiability_0_Q2_USD":918000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":21062000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":11213000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2260000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":73000.0,"ProceedsFromStockPlans_2_Q2_USD":103000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":54000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":28000.0,"CommonStockValue_0_Q2_USD":40000.0,"LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_0_Q2_USD":482000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":11000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1509000.0,"FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_0_Q2_USD":432000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q2_USD":0.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":936000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q2_USD":0.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":7385000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-30459000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-16274000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":5802000.0,"OtherAssetsNoncurrent_0_Q2_USD":8845000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":409964000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1807000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":553955000.0,"Liabilities_0_Q2_USD":16275000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":1210000.0,"ShareBasedCompensation_2_Q2_USD":4037000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2100000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9604231.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":127000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":33000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.017,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-30459000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16274000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2237000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-25757000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":40151802.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":40247110.0,"LiabilitiesCurrent_0_Q2_USD":13979000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-24255000.0,"AccountsPayableCurrent_0_Q2_USD":5806000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":409964000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2313000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1479000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":205000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":145000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":90000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.034,"LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_0_Q2_USD":433000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":103000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":102000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":167000.0,"NetIncomeLoss_2_Q2_USD":-30459000.0,"CommonStockSharesOutstanding_0_Q2_shares":40325270.0,"LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_0_Q2_USD":446000.0,"LeaseCost_1_Q2_USD":172000.0,"LeaseCost_2_Q2_USD":287000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":202000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":531000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"OperatingIncomeLoss_2_Q2_USD":-30507000.0,"OperatingIncomeLoss_1_Q2_USD":-16299000.0,"OperatingLeaseCost_2_Q2_USD":97000.0,"OperatingLeaseCost_1_Q2_USD":62000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":421289000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1769000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4037000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2237000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":78000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":1000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":251000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":834000.0,"OperatingExpenses_2_Q2_USD":30507000.0,"OperatingExpenses_1_Q2_USD":16299000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1812000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.76,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.4,"ProfitLoss_2_Q2_USD":-30459000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2296000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":429000.0,"StockholdersEquity_0_Q2_USD":405014000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-148981000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":200000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":225000.0,"Ticker":"ALXO","CIK":"1810182","name":"ALX ONCOLOGY HOLDINGS INC","OfficialName":"ALX Oncology Holdings Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"632216571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]